PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 16, 20240 citations

Supplementary Figure S5 from Dissecting the mechanisms underlying the Cytokine Release Syndrome (CRS) mediated by T Cell Bispecific Antibodies

View Full Paper
GLGabrielle Leclercq-CohenNSNathalie SteinhoffLSLlucia Albertí Servera

Key Points

Key points are not available for this paper at this time.

Abstract

Supplementary Figure S5. Overview of GO Biological process pathways found enriched in A. CD4+ T cells (6 hrs), B. CD8+ T cells (6 hrs), C. monocytes (6 hrs) and D. neutrophils (4 hrs) after treatment with 0.2 μg/mL CD20-TCB.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Leclercq-Cohen et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db6435875237ffhttps://doi.org/10.1158/1078-0432.27032596
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Supplementary Figure S5 from Dissecting the mechanisms underlying the Cytokine Release Syndrome (CRS) mediated by T Cell Bispecific Antibodies2024
  2. 2Supplementary Figure S2 from Dissecting the mechanisms underlying the Cytokine Release Syndrome (CRS) mediated by T Cell Bispecific Antibodies2024
  3. 3Supplementary Figure S2 from Dissecting the mechanisms underlying the Cytokine Release Syndrome (CRS) mediated by T Cell Bispecific Antibodies2024
  4. 4Supplementary Figure S8 from Dissecting the mechanisms underlying the Cytokine Release Syndrome (CRS) mediated by T Cell Bispecific Antibodies2024
  5. 5Supplementary Figure S6 from Dissecting the mechanisms underlying the Cytokine Release Syndrome (CRS) mediated by T Cell Bispecific Antibodies2024